After decades of being called Polycystic Ovary Syndrome (PCOS), one of the most common hormonal disorders affecting women is getting a new name: Polyendocrine Metabolic Ovarian Syndrome (PMOS).
This change, announced through a global consensus published in The Lancet, marks an important shift in how we understand and talk about this condition. University of Rochester Medicine experts Kathy Hoeger, MD, MPH, from Strong Fertility Center, and endocrinologist Olga Astapova, MD, PhD, explain what the new name means for diagnosis, treatment, and future research.
What Is PMOS?
PMOS stands for Polyendocrine Metabolic Ovarian Syndrome. The new name better reflects what happens in the body:
PMOS is a common condition that affects 1 in 10 women of reproductive age.
Why Was the Name Changed?

Healthcare providers and researchers felt that "Polycystic Ovary Syndrome" was misleading, as it didn't tell the whole story of the condition. The name highlighted ovarian cysts, which not everyone with PMOS develops. It also didn’t acknowledge the condition's broader metabolic and hormonal effects.
The global medical community pushed for this change to:
How Common is PMOS and Why You Might Already Have It?
Polymetabolic Ovarian Syndrome (PMOS), formerly PCOS, is a common but very misunderstood condition. We're here to clear up this and other myths so patients can get the info and treatment they need.
Does the Name Change Affect Diagnosis or Treatment?
Over time, it may change diagnosis and treatment processes slightly.
What won’t change:
Providers will still look for the same combination of symptoms:
What will change over time:
If you're already being treated for PCOS, continue following your provider's recommendations.
PMOS Care at University of Rochester Medicine
Our specialists understand that PMOS affects every aspect of your health. We work with you to create a personalized treatment plan that addresses your unique needs and goals.
